Last 4.90 MYR
Change Today 0.00 / 0.00%
Volume 183.8K
PHRM On Other Exchanges
Kuala Lumpur
As of 3:52 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

pharmaniaga berhad (PHRM) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/25/14 - 4.91
52 Week Low
03/10/14 - 4.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PHARMANIAGA BERHAD (PHRM)

Related News

No related news articles were found.

pharmaniaga berhad (PHRM) Related Businessweek News

No Related Businessweek News Found

pharmaniaga berhad (PHRM) Details

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare company primarily in Malaysia and Indonesia. It operates through Logistics and Distribution, and Manufacturing segments. The company is involved in the manufacture and sale of generic pharmaceutical products; supply, trading, and installation of medical and hospital equipment; trading and wholesale of consumer products; and distribution and trading of pharmaceutical products, medical products, food supplements, and diagnostic products. It also conducts research and development of pharmaceutical products, as well as provides hospital equipping services. The company is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.

pharmaniaga berhad (PHRM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pharmaniaga berhad (PHRM) Key Developments

Pharmaniaga Bhd Declares Third Interim Dividend for the Year Ending December 31, 2014, Payable on December 30, 2014

For the third quarter of 2014, the Directors of Pharmaniaga Bhd have declared a third interim dividend of 8.00 sen per share in respect of the year ending December 31, 2014 against 3.00 sen per share a year ago. The dividend will be paid on December 30, 2014 to shareholders registered in the Register of Members at the close of business on December 9, 2014.

Pharmaniaga Bhd Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Pharmaniaga Bhd reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported profit before taxation of MYR 24,945,000, and profit attributable to owners of the parent of MYR 14,955,000 or 5.78 sen per basic share on revenue of MYR 502,086,000 against profit before taxation of MYR 13,461,000, and profit attributable to owners of the parent of MYR 3,751,000 or 1.45 sen per basic share on revenue of MYR 440,807,000 a year ago period. The group's revenue increased this was translated into a group profit before tax, a significant increase from the previous year's corresponding quarter, largely due to the favourable contribution from operations in the current quarter. For the nine months, the company reported profit before taxation of MYR 87,726,000, and profit attributable to owners of the parent of MYR 57,147,000 or 22.07 sen per basic share on revenue of MYR 1,495,830,000 against profit before taxation of MYR 59,990,000, and profit attributable to owners of the parent of MYR 34,387,000 or 13.28 sen per basic share on revenue of MYR 1,378,779,000 a year ago period. PBT was achieved as a result of strong contributions from operations and continuous improvements in manufacturing as well as reduced operating expenses, including lower amortisation and provision for doubtful debts. Net cash generated from operating activities was MYR 16,046,000 against MYR 100,531,000 a year ago period. Purchase of property, plant and equipment was MYR 24,780,000 against MYR 19,805,000 a year ago. Purchase of intangible assets was MYR 49,437,000 against MYR 11,653,000 a year ago.

Pharmaniaga Berhad Proposes Joint Venture with Modern Healthcare Solutions Company Limited for the Construction and Operation of a Pharmaceutical Manufacturing Plant in the Kingdom of Saudi Arabia

Pharmaniaga Berhad proposed joint venture with Modern Healthcare Solutions Company Limited for the construction and operation of a pharmaceutical manufacturing plant in the Kingdom of Saudi Arabia. The parties had on 17 November 2014 agreed to further extend the long stop date to another 6 months until 16 May 2015 or such later date as both parties shall agree in writing to finalise amongst others, the feasibility study documentations for the purpose of closing. The extension shall be until 16 May 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:MK 4.90 MYR 0.00

PHRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHRM.
View Industry Companies

Industry Analysis


Industry Average

Valuation PHRM Industry Range
Price/Earnings 14.8x
Price/Sales 0.6x
Price/Book 2.3x
Price/Cash Flow 13.1x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMANIAGA BERHAD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at